Insulin price under economical recession pressure

 Insulin, is a strategic pharmaceutical product in the healthcare basket of diabetic people. Insulin known as a hormone that control Blood sugar in diabetic people is one of high tech products of Biotechnology corporations.

The thing that made Insulin is it's unique structure and storage condition.

Russia's economic invasion of Ukraine and China military threaten for Taiwan made a big damage to the chain of primary material supply for biopharmaceutical production.

Medical economists predict that Insulin price will increase by China's military invasion of Taiwan. The thing that is a big threaten against global health security and bio safety. 

Today's Insulin price in the free markets are under control of few companies, but by Russia's energy terrorism will impacts European biotech corporations and China war will impacts Chains of Supply.

Novo Nordisk challenge with Energy for 2022

 Novo Nordisk is a famous bio pharmaceutical brand in global market, but there are challenges against this brand for next 5 years.

Russia's invasion of Ukraine made a big challenge for European countries. Russia started a military invasion and for controlling global response to the war crimes in Ukraine use Oil and gas as a political leverage for returning back to the global community.

Global response to the war crimes in Ukraine was heavy sanctions that paralyzed Russia's economy. Russia's next movement was banning access of European countries to the Asian Energy market, the thing that in short term made a big political and economical pressure on the markets.

One of the energy consuming and heavy high tech industries in Denmark is Novo Nordisk. This company based on the high tech molecular solutions for curing disease become a qualified high trust brand in the market, but there are a big energy challenge for this company next 5 years.

Russia's policy for stopping NATO Partnership ally failed and Sweden and Finland Joined to this military ally, but now there are big political challenge in the market.

First of all, Russia's policy for banning access of European power to the Energy market. Second, China's policy for COVID19 lock down that damage the chains of supply. This will made a delay in production cycle. The big challenge that is a threaten against Brand and employee of this company in mid term.

How China war will impacts Novo Nordisk

 China economic policy for last decades were penetrating through global community economically and using multiple strategies to achieving a share from global market such as Dumping, Copying industrial design and patents.

Economic workers, Low prices and powerful industries made China one of the pioneer suppliers of Biotechnology products and pharmaceutical primary materials.

Novo Nordisk known as a pioneer biotech company in the global ranking, became one of the customers of other countries primary material. The thing that helped China understanding the needs of market and become one more powerful.

China Taiwan military conflict countdown started for 2022, The thing that is a big danger for chains of supply in the Europe and America. Novo Nordisk economical challenge with this war will be serious and soon may damage existence of FDA approved products in the global market.

The thing that is a big damage for stocks price and share holders. Novo Nordisk branding will face big challenge and this will lead to the decrease of penetrating rate through the market. 

In other hands, price of products will increase and some products will enter to the luxury baskets and become luxury cure methods. It seems that Lars Fruergaard Jørgensen should be ready for a big economic recession in the company and choosing a new strategy for short term.

Short review about Novo Nordisk CEO: Lars Fruergaard Jørgensen

 Novo Nordisk is one of the pioneer biopharmaceutical and biotechnology corporation in the global ranking. This company with multi branch policy all around the world hire about 48478 employee and develop new Cure methods based on the molecular solutions. 

Novo Nordisk recognized by Diabetic cure solution all around the world, but this company is one pioneer molecular developer for diseases.

Lars Fruergaard Jørgensen as a CEO of Novo Nordisk born on 1966 in Denmark. He has master science of Finance and business management from Aarhus University. His salary in Novo Nordisk is about 5,424,793 USD annually.

Pharmasyntez : Russian pharmaceutical company challenge for 2022

 Pharmasyntez is one of the Russia's corporations active in developing pharmaceutical products and small molecules.

By Russia's invasion of Ukraine and global response to this war crime by heavy sanctions that paralyzed Russia's money and banking system, Primary reports shows that this company is facing big problems from finding professions to the financing R&D Projects

One of the strategic challenge for this Russian company is to access molecular resources and technologies for the research in the laboratories and factories. The thing that under heaviest sanctions of free world economies, made activity of this corporation very hard. 

Russia's sanctions impacts on the Biopharmaceutical industries

Russia's biopharmaceutical industries are the heart of healthcare and medical system of Russia. The thing that after Russia's invasion of Ukraine and heavy sanctions that paralyzed Russia's money and banking system by banning access of SWIFT faced big financial problems.

Russia's Biopharmaceutical industries now facing big challenge for finance and supplying primer resources for pharmaceutical products.

Money and banking system sanctions, totally stop Russia's foreign trade and Russia's GDP failed by 2022. Economists predict that damaging to the Russia's economic infrastructures and exit of entrepreneurs and capital flight are big threaten against Russia's biopharmaceutical industries and this will be a threaten against social immunity against next pandemic and social medical problems.

The thing that in short term will threaten Kremlin political system existence and is a warning for the Russia's political and economical system. Medical security index under heaviest sanctions of west will fall down and it's a big risk for the Russia's healthcare programs.